MEG3 and neoplasm: We found that hypermethylation of MEG3 DMR sites within a CTCF binding domain is associated with increased miRNA expression (potentially by inhibiting CTCF binding and its enhancer-blocking effect as described above) and higher tumor aggressiveness.